• Dr. Stefan Jentzsch, Partner at the global investment firm Perella Weinberg Partners has been appointed to Avextra’s Supervisory Board, bringing decades of experience in corporate finance, M&A, and investment banking to the company. 
  • His distinguished career in investment banking includes roles as member of the Management Board at the Dresdner Bank and the HypoVereins Bank and Partner Goldman Sachs. He is also a Trustee of Kinderhilfestiftung and Chairman of the R.E.S.P.E.K.T. foundation.
  • Mr. Jentzsch will support Avextra’s strategic growth and capital raises as the company strengthens its position as a European innovation leader in medicinal cannabis.

Bensheim, Germany, April 3, 2025 – Avextra, a leading European manufacturer of cannabis-based medicines, is pleased to announce the appointment of Stefan Jentzsch to its Supervisory Board. With decades of experience in the financial sector and a proven track record in corporate strategy, M&A, and investment banking, Mr. Jentzsch will bring invaluable expertise to Avextra as the company continues to expand its operations across Europe and executes its clinical program. 

EN